hotspot -WSS

hotspot

author：entertainment 2025-10-01 05:40:12 - browse：22482

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Involuntary treatment for addiction doesn't work

WSS

Trump demands the U.S. pay no more for drugs than other countries … again

Georgia court denies Trump's request to quash DA's 2020 election probe

State Dept. review finds Biden bears some blame for Afghanistan failures

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Sports medicine is finally prioritizing gender equality

How one medical school became remarkably diverse

leisure time

hotspot

hotspot

Affirmative action in medical school literally saved lives

BioMarin wins approval for gene therapy to treat hemophilia A

Hepatitis C has a cure — but many Americans still lack access to it

Heart attack and stroke risk calculators need revising

Jerome Adams on the need for new antivirals for Covid

Involuntary treatment for addiction doesn't work

Psychedelics group wrestles with new pharma identity

Medical records are filled with copy

The cancer drug shortage isn’t new — and neither are the solutions

Woman gored by Bison at Yellowstone

Wikipedia

Congress likely to miss an opportunity to fix drug shortages issue

As demand for Covid shots wanes, Moderna seeks its next success

Sports medicine is finally prioritizing gender equality

J&J expands global access to TB drug amid advocacy campaign

Cancer drug shortages should be causing more outrage

Alkermes shareholders re

focus

hotspot

hotspot

hotspot